MedTrace Logo

Early Life Anemia and Children's Risk of Neurodevelopmental Disorders: National and Regional Register-based Studies

NCT06199362 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2400000

Last updated 2024-01-10

No results posted yet for this study

Summary

The overall project aim is to study children's neurodevelopmental outcomes (including diagnoses of autism, ADHD, and intellectual disability) following exposure to maternal anemia during pregnancy or anemia during the first year of life using national and regional Swedish health-data registers, and to assess children's neurodevelopmental outcomes over the range of maternal hemoglobin levels during pregnancy.

Conditions

  • Neurodevelopmental Disorders
  • Autism
  • ADHD
  • Intellectual Disability
  • Anemia

Sponsors & Collaborators

Principal Investigators

  • Renee M. Gardner, PhD · Karolinska Institutet

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-15
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06199362 on ClinicalTrials.gov